The Annex to Implementing Regulation (EU) 2018/1882, as recently amended by Commission Implementing Regulation (EU) 2026/169 [Commission Implementing Regulation (EU) 2026/169 of 26 January 2026 amending the Annex to Implementing Regulation (EU) 2018/1882 concerning the categorisation of infection with bluetongue virus (serotypes 1-24) as a listed disease (OJ L, 2026/169, 27.1.2026, ELI: http://data.europa.eu/eli/reg_impl/2026/169/oj).], re-categorised infection with BTV as a category D+E disease, instead of as a category C+D+E disease. As a consequence of such re-categorisation, the rules, laid down in Articles 68 point (c) and 69 point (c) of Delegated Regulation (EU) 2020/687, relating to infection with BTV, including the disease control measures in the case of the suspicion or the confirmation of an outbreak of infection with BTV in a disease-free zone are no longer relevant, as they only apply to a category C disease. Therefore, the references to infection with BTV should be deleted from Articles 68, point (c), and 69, point (c) of Delegated Regulation (EU) 2020/687. Delegated Regulation (EU) 2020/687 should, therefore, be amended accordingly.
Recital 4, Regulation (EU) 2026/796
In forcesince 27 Mar 2026